275
Views
65
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Uveal and Conjunctival Malignant Melanoma in Denmark, 1943–97: Incidence and Validation Study

, , , , , & show all
Pages 223-232 | Received 04 Nov 2004, Accepted 14 Mar 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Krishnaraj Mahendraraj, Sneha Shrestha, Christine SM Lau & Ronald S Chamberlain. (2017) Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973–2012). Clinical Ophthalmology 11, pages 153-160.
Read now
Krishnaraj Mahendraraj, Christine SM Lau, Injoon Lee & Ronald S Chamberlain. (2016) Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012). Clinical Ophthalmology 10, pages 2113-2119.
Read now
James R Wong, Afshan A Nanji, Anat Galor & Carol L Karp. (2014) Management of conjunctival malignant melanoma: a review and update. Expert Review of Ophthalmology 9:3, pages 185-204.
Read now
Li-Anne Lim, Michele C Madigan & R Max Conway. (2013) Conjunctival melanoma: a review of conceptual and treatment advances. Clinical Ophthalmology 7, pages 521-531.
Read now
Dawn Russell-Hermanns, Bruno Fernandes, Srijana PV & Miguel Burnier Jr. (2010) Eye growth transformation: uveal melanoma. Expert Review of Ophthalmology 5:4, pages 501-511.
Read now
P. Isager, G. Engholm, J. Overgaard & H. Storm. (2006) Uveal and Conjunctival Malignant Melanoma in Denmark 1943–97: Observed and Relative Survival of Patients Followed Through 2002. Ophthalmic Epidemiology 13:2, pages 85-96.
Read now
Peter Isager, Niels Ehlers, Steen F Urbak & Jens Overgaard. (2006) Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma. Acta Oncologica 45:3, pages 285-293.
Read now
Tara A. Young & Johanna M. Seddon. (2005) Choroidal and Cutaneous Melanoma: Distinctly Different Cousins. Ophthalmic Epidemiology 12:4, pages 221-222.
Read now

Articles from other publishers (57)

Gabriela Estefanía Pacheco-Callirgos, Ciro García-Alvarez, Luis Garcia-Onrubia, David Miguel-Pérez, Pilar Alonso-Martinez, Patricia Diezhandino, Jesus Maria de Frutos Barajas & Maria Antonia Saornil-Alvarez. (2023) Brachytherapy in the prevention of recurrence of conjunctival melanoma. Strahlentherapie und Onkologie 199:11, pages 1025-1030.
Crossref
Mike Wu, Serdar Yavuzyiğitoğlu, Erwin Brosens, Wishal D. Ramdas & Emine Kiliç. (2023) Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors. Investigative Opthalmology & Visual Science 64:13, pages 45.
Crossref
Maria Chiara Gelmi, Laurien E. Houtzagers, Thomas Strub, Imène Krossa & Martine J. Jager. (2022) MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance. International Journal of Molecular Sciences 23:11, pages 6001.
Crossref
I. Yu. Zherkо, P. D. Dziameshkо, L. V. Naumenko, I. I. Minailо, E. P. Zhyliayeva, O. A. Hizemava & O. A. Navasel’skaya. (2022) The immediate results of choroidal melanoma treatment using stereotactic radiosurgery. Diagnostic radiology and radiotherapy 13:1, pages 95-102.
Crossref
Niels J. Brouwer, Robert M. Verdijk, Steffen Heegaard, Marina Marinkovic, Bita Esmaeli & Martine J. Jager. (2022) Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options. Progress in Retinal and Eye Research 86, pages 100971.
Crossref
Isabel Smidt‐Nielsen, Mette Bagger, Steffen Heegaard, Klaus Kaae Andersen & Jens Folke Kiilgaard. (2021) Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70‐year nationwide cohort. Acta Ophthalmologica 99:8.
Crossref
Maria Vittoria Cicinelli, Maura Di Nicola, Carmen Rosaria Gigliotti, Marco Battista, Elisabetta Miserocchi, Antonella del Vecchio, Pietro Mortini, Francesco Bandello & Giulio Maria Modorati. (2021) Predictive factors of radio‐induced complications in 194 eyes undergoing gamma knife radiosurgery for uveal melanoma. Acta Ophthalmologica 99:8.
Crossref
Yu-Yun Huang, Tzu-Yu Hou, Wei-Kuang Yu, Chieh-Chih Tsai, Shu-Ching Kao, Wen-Ming Hsu & Jui-Ling (Catherine) Liu. (2021) The Clinical Feature and Treatment Outcome of Ocular Melanoma: A 34-Year Experience in a Tertiary Referral Center. Cancers 13:23, pages 5926.
Crossref
Melissa Chalada, Charmaine A. Ramlogan-Steel, Bijay P. Dhungel, Amanda Y. Goh, Samuel Gardiner, Christopher J. Layton & Jason C. Steel. (2021) Differences in Uveal Melanoma Age-Standardized Incidence Rates in Two Eastern States of Australia Are Driven by Differences in Rurality and Ultraviolet Radiation. Cancers 13:23, pages 5894.
Crossref
Sacha Nahon-Estève, Corine Bertolotto, Alexandra Picard-Gauci, Lauris Gastaud, Stéphanie Baillif, Paul Hofman, Anaïs Groulier, Célia Maschi, Jean-Pierre Caujolle, Sandra Lassalle & Arnaud Martel. (2021) Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives. Cancers 13:22, pages 5691.
Crossref
Ortal Zaks, Dimitri Gaber, Keren Ben-Yaakov, Maya Sharvit-Bader, Alexa Goz, Ziv Rotfogel, Shahar Ish-Shalom, Evgeniya Kesler, Ady Yosepovich, Hana Leiba, Martine J. Jager, Arie L. Marcovich & Michal Aharoni-Simon. (2021) In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma. Experimental Eye Research 204, pages 108431.
Crossref
Christine D.M. Roelofsen, Annemijn P.A. Wierenga, Sjoerd van Duinen, Robert M. Verdijk, Jaco Bleeker, Marina Marinkovic, Gregorius P.M. Luyten & Martine J. Jager. (2021) Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time. Ocular Oncology and Pathology 7:2, pages 133-141.
Crossref
Katarina Cisarova, Marc Folcher, Ikram El Zaoui, Rosanna Pescini-Gobert, Virginie G. Peter, Beryl Royer-Bertrand, Leonidas Zografos, Ann Schalenbourg, Michael Nicolas, Donata Rimoldi, Serge Leyvraz, Nicolò Riggi, Alexandre P. Moulin & Carlo Rivolta. (2020) Genomic and transcriptomic landscape of conjunctival melanoma. PLOS Genetics 16:12, pages e1009201.
Crossref
Natasha M. van Poppelen, Daniël P. de Bruyn, Tolga Bicer, Rob Verdijk, Nicole Naus, Hanneke Mensink, Dion Paridaens, Annelies de Klein, Erwin Brosens & Emine Kiliҫ. (2020) Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing. International Journal of Molecular Sciences 22:1, pages 336.
Crossref
Kalijn Fredrike Bol, Marco Donia, Steffen Heegaard, Jens Folke Kiilgaard & Inge Marie Svane. (2020) Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know. International Journal of Molecular Sciences 21:15, pages 5231.
Crossref
Lauge Hjorth Mikkelsen. (2020) Molecular biology in conjunctival melanoma and the relationship to mucosal melanoma. Acta Ophthalmologica 98, pages 1-27.
Crossref
Raj Kishor Bisht, Gopishankar Natanasabapathi & Shashank Sharad Kale. (2020) Quantitative analysis of Gamma Knife stereotactic radiosurgery for uveal melanoma. Polish Journal of Medical Physics and Engineering 26:2, pages 111-117.
Crossref
Gianni Virgili, Mariacristina Parravano, Gemma Gatta, Riccardo Capocaccia, Cinzia Mazzini, Sandra Mallone & Laura Botta. (2020) Incidence and Survival of Patients With Conjunctival Melanoma in Europe. JAMA Ophthalmology 138:6, pages 601.
Crossref
Teresa Rauchegger, Georgios Blatsios, Gertrud Haas, Claus Zehetner & Nikolaos E. Bechrakis. (2019) Zehn Jahre multimodale Therapie uvealer Melanome an der Universitätsaugenklinik Innsbruck10 years of multimodal treatment of uveal melanoma at the Department of Ophthalmology, Medical University of Innsbruck. Spektrum der Augenheilkunde 34:1, pages 18-25.
Crossref
Giulio Maria Modorati, Roi Dagan, Lauge Hjorth Mikkelsen, Simon Andreasen, Alfio Ferlito & Francesco Bandello. (2020) Gamma Knife Radiosurgery for Uveal Melanoma: A Retrospective Review of Clinical Complications in a Tertiary Referral Center. Ocular Oncology and Pathology 6:2, pages 115-122.
Crossref
Jonathan E. Lu, Jessica R. Chang, Jesse L. Berry, Gino K. In & Sandy Zhang-Nunes. (2020) Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma. International Ophthalmology Clinics 60:2, pages 77-89.
Crossref
Ezekiel Weis, Sebastian Q. Vrouwe, David B. LeBaron, Matthew B. Parliament, Jerry Shields & Carol L. Shields. (2019) Changes in Ultraviolet Radiation Exposure to the Ocular Region: A Population-Based Study. Cancers 11:5, pages 719.
Crossref
Shireen Khattak, Neeru Gupta, Xun Zhou, Layla Pires, Brian C. Wilson & Yeni H. Yucel. (2019) Non-invasive dynamic assessment of conjunctival melanomas by photoacoustic imaging. Experimental Eye Research 179, pages 157-167.
Crossref
Snježana Kaštelan, Antonela Gverović Antunica, Lidija Beketić Orešković, Jasminka Salopek Rabatić, Boris Kasun & Ivana Bakija. (2018) Conjunctival Melanoma - Epidemiological Trends and Features. Pathology & Oncology Research 24:4, pages 787-796.
Crossref
Niels J Brouwer, Marina Marinkovic, Sjoerd G van Duinen, Jaco C Bleeker, Martine J Jager & Gregorius P M Luyten. (2018) Treatment of conjunctival melanoma in a Dutch referral centre. British Journal of Ophthalmology 102:9, pages 1277-1282.
Crossref
Natasha M. van Poppelen, Serdar Yavuzyigitoglu, Kyra N. Smit, Jolanda Vaarwater, Bert Eussen, Tom Brands, Dion Paridaens, Emine Kiliç & Annelies de Klein. (2018) Chromosomal rearrangements in uveal melanoma: Chromothripsis. Genes, Chromosomes and Cancer 57:9, pages 452-458.
Crossref
Natasha M. van Poppelen, Jolanda Vaarwater, Hardeep S. Mudhar, Karen Sisley, Ian G. Rennie, Paul Rundle, Tom Brands, Quincy C.C. van den Bosch, Hanneke W. Mensink, Annelies de Klein, Emine Kiliç & Robert M. Verdijk. (2018) Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential. Ophthalmology 125:6, pages 904-912.
Crossref
Manni Singh, Priya Durairaj & Jensen Yeung. (2018) Uveal Melanoma: A Review of the Literature. Oncology and Therapy 6:1, pages 87-104.
Crossref
Lauge Hjorth Mikkelsen & Steffen Heegaard. 2018. Melanoma. Melanoma 253 272 .
Joel M. Mor & Ludwig M. Heindl. (2017) Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma. Ocular Oncology and Pathology 3:2, pages 133-141.
Crossref
Jeanie Ling, Robert Tauscher, Viraj Mehta, Matthew Zhang, Anthony Daniels & Sahar Kohanim. (2017) The Role for Sentinel Lymph Node Biopsy in the Management of Conjunctival Melanoma. International Ophthalmology Clinics 57:1, pages 87-101.
Crossref
Ann-Cathrine Larsen, Christina Dahl, Christina M. Dahmcke, Johanne Lade-Keller, Volkert D. Siersma, Peter B. Toft, Sarah E. Coupland, Jan U. Prause, Per Guldberg & Steffen Heegaard. (2016) BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions . Acta Ophthalmologica 94:5, pages 463-470.
Crossref
Ann-Cathrine Larsen. (2016) Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Acta Ophthalmologica 94, pages 1-27.
Crossref
Myron Yanoff & Joseph W. Sassani. 2015. Ocular Pathology. Ocular Pathology 589 648.e12 .
Ann-Cathrine Larsen, Line Holst, Bogumil Kaczkowski, Morten T. Andersen, Valentina Manfé, Volkert D. Siersma, Miriam Kolko, Jens F. Kiilgaard, Ole Winther, Jan U. Prause, Robert Gniadecki & Steffen Heegaard. (2014) MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma. Acta Ophthalmologica 92:6, pages 541-549.
Crossref
Timothy G Murray & H Culver BoldtTero Kivelä. 2014. Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies. Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies 20 38 .
Jacob Pe’er & Robert Folberg. 2014. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 185 194 .
N. Vicente, M.A. Saornil, C. García-Álvarez, A. Almaraz, P. Alonso Martínez, J.M. Frutos-Baraja & F. López-Lara. (2013) Uveal melanoma: Clinical characteristics, treatment and survival in a series of 500 patients. Archivos de la Sociedad Española de Oftalmología (English Edition) 88:11, pages 433-438.
Crossref
N. Vicente, M.A. Saornil, C. García-Álvarez, A. Almaraz, P. Alonso Martínez, J.M. Frutos-Baraja & F. López-Lara. (2013) Melanoma uveal: características clínicas, tratamiento y supervivencia en una serie de 500 pacientes. Archivos de la Sociedad Española de Oftalmología 88:11, pages 433-438.
Crossref
Lauren G. Aoude, Karin Wadt, Anders Bojesen, Dorthe Crüger, Åke Borg, Jeffrey M. Trent, Kevin M. Brown, Anne-Marie Gerdes, Göran Jönsson & Nicholas K. Hayward. (2013) A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers. PLoS ONE 8:8, pages e72144.
Crossref
N Kenawy, S L Lake, S E Coupland & B E Damato. (2012) Conjunctival melanoma and melanocytic intra-epithelial neoplasia. Eye 27:2, pages 142-152.
Crossref
Felicia Fountain & Hans E. Grossniklaus. 2012. Pocket Guide to Ocular Oncology and Pathology. Pocket Guide to Ocular Oncology and Pathology 377 380 .
I. Franco-Lie, T. Iversen, T.E. Robsahm & M. Abdelnoor. (2011) Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956–2005. Annals of Oncology 22:6, pages 1443-1450.
Crossref
Ian W. McLean & J. Douglas Cameron. 2011. Cornea. Cornea 477 484 .
Marie Louise Roed Rasmussen, Jan Ulrik Prause, Martin Johnson, Finn Kamper-Jørgensen & Peter Bjerre Toft. (2010) Review of 345 eye amputations carried out in the period 1996-2003, at Rigshospitalet, Denmark. Acta Ophthalmologica 88:2, pages 218-221.
Crossref
Jean-Pierre Droz, Isabelle Ray-Coquard & Jean-Louis PeixJean -Daniel Grange, Laurent Kodjikian & Joël Gambrelle. 2010. Tumeurs malignes rares. Tumeurs malignes rares 127 132 .
Nils Eide, Ragnar S. Faye, Hanne K. Høifødt, Ralf Ãvergaard, Peter Jebsen, Gunnar Kvalheim & Ãystein Fodstad. (2009) Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients. Acta Ophthalmologica 87:8, pages 830-836.
Crossref
B. van Etten, J.H.W. de Wilt, F. Brunstein, A.M.M. Eggermont & C. Verhoef. (2009) Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. European Journal of Surgical Oncology (EJSO) 35:5, pages 539-545.
Crossref
J Krohn, O R Monge, T N Skorpen, S J Mørk & O Dahl. (2007) Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye 22:11, pages 1398-1403.
Crossref
Ghassan Ayish Alyahya. (2008) Melanoma Associated Spongiform Scleropathy: Characterization, Biochemical and Immunohistochemical studies. Acta Ophthalmologica 86:thesis3, pages 1-25.
Crossref
Jørgen Krohn & Olav Dahl. (2008) Incidence of iris melanoma in western Norway. Acta Ophthalmologica 86:1, pages 116-117.
Crossref
Thomas Seregard & Eugenio Triay. 2008. Cornea and External Eye Disease. Cornea and External Eye Disease 201 216 .
Gianni Virgili, Gemma Gatta, Laura Ciccolallo, Riccardo Capocaccia, Annibale Biggeri, Emanuele Crocetti, Jean-Michel Lutz & Eugenio Paci. (2007) Incidence of Uveal Melanoma in Europe. Ophthalmology 114:12, pages 2309-2315.e2.
Crossref
Jens Lindegaard. (2007) Primary and secondary tumours of the optic nerve, with emphasis on invasion by uveal malignant melanoma. Acta Ophthalmologica Scandinavica 85:thesis1, pages 1-22.
Crossref
. (2007) Malignant Melanoma of the Conjunctiva in Children: A Review of the International Literature 1965–2006. Journal of Pediatric Ophthalmology & Strabismus 44:5, pages 277-282.
Crossref
Jacob Pe'er & Robert Folberg. 2007. Clinical Ophthalmic Oncology. Clinical Ophthalmic Oncology 146 149 .
Ghislaine Scélo, Paolo Boffetta, Philippe Autier, Kari Hemminki, Eero Pukkala, Jorgen H. Olsen, Elisabete Weiderpass, Elizabeth Tracey, David H. Brewster, Mary L. McBride, Erich V. Kliewer, Jon M. Tonita, Vera Pompe-Kirn, Kee-Seng Chia, Jon G. Jonasson, Carmen Martos, Michael Giblin & Paul Brennan. (2007) Associations between ocular melanoma and other primary cancers: An international population-based study. International Journal of Cancer 120:1, pages 152-159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.